QB3
Berkeley, Californiaqb3.org
Overview
QB3 is a nonprofit research and technology commercialization institute affiliated with the University of California campuses at Berkeley, San Francisco, and Santa Cruz . QB3 supports early-stage commercialization in biotech and pharma, and conducts basic and applied research . The institute connects scientists to each other and to resources, enabling them to bring new technologies to market . QB3 operates a network of incubators, providing laboratory space for early-stage biotech companies .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Kopra Bio | Jan 2025 | Grant | Co-investor |
| Gravitas Medical, Inc. | Sep 2022 | Series A Extension | Co-investor |
| Halo Biosciences | Nov 2019 | Accelerator | Co-investor |
| Allysta Pharmaceuticals | Feb 2017 | Accelerator | Co-investor |
| CellFE | - | Accelerator | Co-investor |
Key People
David Schaffer
Director
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
